Hammoudi, Nadjib
Watanabe, Shin
Bikou, Olympia
Ceccaldi, Alexandre
Fish, Kenneth
Yamada, Kelly P.
Miyashita, Satoshi
Lebreton, Guillaume
Hajjar, Roger J.
Ishikawa, Kiyotake http://orcid.org/0000-0002-8287-3483
Funding for this research was provided by:
National Institutes of Health (HL139963, HL117505, HL 119046, HL129814, HL128072, HL131404, HL135093, HL112324, GTRP)
American Heart Association (17SDG33410873)
Fondation Leducq (N/A)
Deutsche Herzstiftung
Article History
Received: 6 February 2018
Accepted: 13 May 2018
First Online: 29 May 2018
Compliance with Ethical Standards
:
: No human studies were carried out by the authors for this article.
: All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
: K.I. received a research grant from Abiomed Inc. (Danvers, MA) and the Impella device was provided from the company. N.H. reports consulting/advisory activities for Philips. G.L. received a research grant from Abiomed Inc. not related to current study.